The antibodies produced by individuals who fought off H1N1 (swine flu) infection last year may bring researchers one step closer to their quest to develop a “universal” flu vaccine, U.S. researchers said Monday, HealthDay News/Bloomberg Businessweek reports. As the researchers from Emory University and the University of Chicago report in the Jan. 10 issue of the Journal of Experimental Medicine, “people who were infected with the H1N1 virus and recovered had a special immune response, producing antibodies that protect against a wide variety of flu strains,” the news service writes (1/10).
Also In Global Health News: Global Risks Report; Japan’s Donation To WFP; Global Fund Freeze On Ivory Coast; Pneumonia Vaccine In Kenya
World Economic Forum Global Risks Report Highlights Concerns Over Demand For Food, Water “Nations are in no position to deal with any more big shocks, the World Economic Forum said on Wednesday, yet risks are rising with the threat of ‘disastrous impacts,'” the organization noted in its Global Risks 2011…
The World Bank on Tuesday “announced a $15 million grant to Haiti to fight a persistent cholera epidemic,” SAPA/Health24 reports. In a press release, the bank said it approved an additional $5 million to be added to a previously announced $10 million grant. “The funds, said the organisation in [the] statement, will go towards public campaigns to prevent infection and increase the capacity of Haiti’s health ministry to deal with the emergency,” the news service writes (1/19).
During the WHO’s executive board meeting Monday, WHO Director-General Margaret Chan expressed concerns over what she called a “‘worrisome’ public mistrust of vaccines, following signs of a tail-off in flu vaccination,” Agence France-Presse reports (1/18).
RTS,S Offers 46 Percent Protection Against Malaria For At Least 15 Months After Vaccination, Study Finds
A Phase II trial published Friday in Lancet Infectious Diseases has shown that RTS,S, the “experimental malaria vaccine from GlaxoSmithKline provides African children with long-lasting protection” against malaria, Reuters reports. “Scientists conducting the mid-stage trial at the Kenya Medical Research Institute said results showing the shot offered 46 percent protection for 15 months meant it had ‘promise as a potential public health intervention against childhood malaria in malaria endemic countries’,” the news service notes (Kelland, 1/14).
Sufficient Support Of GAVI Would Go Long Way ToÂ Preventing Premature Deaths Around The WorldÂ “Vaccines are among the greatest scientific contributions to human welfare. They are also some of the largest humanitarian contributions of developed nations to the rest of the world. So it is unfortunate that a decade of…
Dominican Republic Reports Country’s First Cholera Death Following Outbreak In Haiti “Dominican Republic on Sunday confirmed that a 53-year-old Haitian man has become the country’s first death from cholera and announced the immediate start of a broad disease control and monitoring operation” around the eastern town of Higuey where he…
Individuals traveling across East Africa on Friday were ordered to begin receiving mandatory yellow fever vaccines in an effort “to contain an outbreak of the disease in Uganda,” which has sickened an estimated 190 people, resulting in 48 deaths as of Dec. 30, 2010, the Citizen reports (Ubwani, 1/22).
Al Jazeera examines the toll pneumonia and diarrhea take on children living in developing countries and how the GAVI Alliance is working to help improve health outcomes among children through the distribution of pneumonia vaccines around the world.
Insecticides To Fight Malaria: In a Daily Caller opinion piece, Richard Tren of Africa Fighting Malaria andÂ Donald Roberts of the Uniformed Services University of the Health Sciences write in support of using insecticides, like DDT, to combat malaria: “Unless the donor nations that fund global malaria programs, such as the…